Adverse Drug Reaction News Bulletins
ADR News Bulletin 2019 September (Volume 21 Number 2)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
1 September 2019
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Risk of serious liver injury with Esmya® (ulipristal acetate)
AE Case in Focus: Test Yourself
Biotin interference with clinical laboratory tests
Risk of acute pancreatitis and congenital malformations associated with the use of carbimazole or thiamazole
What to do if you suspect a product defect
Regulatory update on biosimilars
List of Dear Healthcare Professional Letters
Answers to AE Case in Focus: Test Yourself
Click on the link below to download the issue in pdf: